Master Protocol for the Phase 1 Study of Cell Therapies in Multiple Myeloma
Master protocol for cell therapy, Phase 1 proof-of-concept studies., in relapsed and refractory multiple myeloma and includes long-term safety follow-up.
Master Protocol for the Phase 1 Study of Cell Therapies for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma, including Long-term Safety Follow-up
- ClinicalTrials.gov Identifier: NCT04155749
- Protocol Number: 19-253
Contact the research team to learn more about this study.
Fields marked with asterisk (*) are required